Pharmacy benefit manager Medco Health Solutions has launched a medical benefit management program that it said would help control spending on specialty drugs, the company said.
Fake versions of a cancer drug made by Roche's U.S. unit have entered the United States, the Food and Drug Administration warned Wednesday.
A pharmacy benefit management organization has received accreditation for its specialty pharmacy program.
The Food and Drug Administration will review a regulatory approval application from Pfizer for a drug to treat an extremely rare and fatal degenerative disease, Pfizer said Wednesday.
Drug maker Biogen Idec plans to spend up to more than $560 million to buy a company developing treatments for organ failure.
The Food and Drug Administration is giving priority review to a drug made by Gilead Sciences that the company is investigating for the prevention of HIV.
Bristol-Myers Squibb has completed its acquisition of a developer of hepatitis C treatments.
Valeant Pharmaceuticals is set to acquire a privately owned ophthalmic biotechnology company, the drug maker said Monday.
An expert panel at the Food and Drug Administration has given a thumbs-down to a drug made by Astex Pharmaceuticals and Eisai for which the two had sought approval as a treatment for leukemia.
The Food and Drug Administration reached a major milestone on the path to a regulatory regime for follow-on biologics on Thursday with the release of draft guidance on biosimilar product development.